It is revealed that obesity is associated with coordinated immune-metabolic remodeling in TNBC, characterized by checkpoint enrichment and lipid dysregulation, which may help explain the enhanced anti-PD-1 responsiveness and should be taken into account in the field of precision medicine.
P. Ji, Huai-Liang Wu, Li-Huan He et al.· Cancer Letters· 0 citations
A previously unrecognized VCP‐LMF2‐HMGCS1 regulatory axis that drives TNBC progression and chemoresistance is unveiled, and lipase maturation factor 2 is identified as a promising therapeutic target for this recalcitrant disease.
Qian Zhao, Lisa Andriani, Yin-Ling Zhang et al.· Advancement of science· 0 citations
Objective
Age-associated molecular heterogeneity is well described in female breast cancer but remains insufficiently characterized in male breast cancer (MBC). We profiled age-stratified clinical and molecular differences between younger (≤55 years) male breast cancer (YMBC) and older (>55 years) male breast cancer (O...
Zhi-Shuang Gao, Ze-Hao Wang, Yue Zhou et al.· Chinese journal of cancer re...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.